István T.
- Country
- Hungary
- Department
- Belgyógyászati Klinika "B" Building
Research Overview
- Evaluation of the Efficacy and Safety of Obeticholic Acid and Bezafibrate in Patients with Primary Biliary Cholangitis Unresponsive or Intolerant to Ursodeoxycholic Acid
- Phase III Double-Blind, Randomized, Placebo-Controlled Study of Norursodeoxycholic Acid in Primary Sclerosing Cholangitis Patients
- Evaluation of Norucholic Acid in the Treatment of Primary Sclerosing Cholangitis: An Open-Label Study
Data & Insights
Has run more than one trial at 27 of 42 partner sites.
Specializations
Hepatobiliary Disorders
The investigator specializes in treating chronic liver conditions, with particular expertise in Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis (PBC). Their research activities demonstrate a deep understanding of progressive cholestatic liver diseases.
- Bile Duct Disorders
- Chronic Liver Diseases
- Cholestatic Conditions
They focus on evaluating novel therapeutic approaches for biliary diseases.
Therapeutic Innovation
The investigator explores innovative treatment options including norursodeoxycholic acid and norucholic acid for cholangitis management. Their work encompasses the evaluation of combination therapies for enhanced treatment outcomes.
- Novel Therapeutic Compounds
- Combination Treatment Approaches
- Disease Progression Prevention
Their research examines both single-agent and combination therapeutic strategies.
Clinical Assessment
The investigator's expertise includes monitoring biochemical disease markers and evaluating treatment responses in liver conditions. They assess key indicators including alkaline phosphatase and other liver enzymes.
- Biomarker Analysis
- Safety Assessment
- Treatment Efficacy Evaluation
Their work involves comprehensive monitoring of hepatobiliary health indicators.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.